PLEASANTON, Calif., April 25,
2023 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq:
TXG), a life sciences leader focused on mastering biology to
advance human health, today announced that members of its
management team will participate in a fireside chat at the BofA
Securities 2023 Healthcare Conference on Wednesday, May 10, at 2:20
p.m. Pacific Time.
Interested parties may access a live webcast of the fireside
chat on the "Investors" section of the company's website
at: https://investors.10xgenomics.com/. The webcast will be
archived and available for replay for at least 45 days after the
event.
About 10x Genomics
10x Genomics is a life science technology company building
products to interrogate, understand and master biology to advance
human health. Our integrated solutions include instruments,
consumables and software for analyzing biological systems at a
resolution and scale that matches the complexity of biology. 10x
Genomics products have been adopted by researchers around the world
including in all of the top 100 global research institutions as
ranked by Nature in 2021 based on publications and all of the top
20 global pharmaceutical companies by 2021 research and development
spend and have been cited in over 4,500 research papers on
discoveries ranging from oncology to immunology and neuroscience.
Our patent portfolio comprises more than 1,750 issued patents and
patent applications.
Disclosure Information
10x Genomics uses filings with the Securities and Exchange
Commission, its website (www.10xgenomics.com), press releases,
public conference calls, public webcasts and its social media
accounts as means of disclosing material non-public information and
for complying with its disclosure obligations under Regulation
FD.
Contacts
Investors: investors@10xgenomics.com
Media: media@10xgenomics.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/10x-genomics-to-present-at-the-bofa-securities-2023-healthcare-conference-301807438.html
SOURCE 10x Genomics, Inc.